Pharmacological Actions of Multi-Target-Directed Evodiamine
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
Evodiamine, a naturally occurring indole alkaloid, is one of the main bioactive ingredients of Evodiae fructus. With respect to the pharmacological actions of evodiamine, more attention has been paid to beneficial effects in insults involving cancer, obesity, nociception, inflammation, cardiovascular diseases, Alzheimer's disease, infectious diseases and themoregulative effects. Evodiamine has evolved a superior ability to bind various proteins, so we also argue that it is good starting point for multi-target drugs. This review is primarily addressed to the description of the recent advances in the biological activity studies of evodiamine, with a focus on pharmacological mechanism. The present review also includes the pharmacokinetics and the detailed exploration of target-binding properties of evodiamine in an attempt to provide a direction for further multi-target drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Nitric oxide as a secretory product of mammalian cells
Nathan, C. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.12.1381691 · Cited by 4,350
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 1×
“Alzheimer’s disease (AD) is a progressive, irreversible brain disease caused by degeneration of synapses and death of neurons, resulting in cognitive, memory and behavioral impairments [68,69].”
BackgroundThe Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
Caterina, M. J., & Julius, D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.487 · Cited by 1,575 · cited 1×
“It is well known that transient receptor potential cation channel subfamily V member 1 (TRPV1) plays a fundamental role in modulation of pain [84].”
BackgroundCloning of a Factor Required for Activity of the Ah (Dioxin) Receptor
Hoffman, E. C., Reyes, H., Chu, F.-F., Sander, F., Conley, L. H., Brooks, B. A., & Hankinson, O. (1991) · Science · doi:10.1126/science.1852076 · Cited by 957 · cited 1×
“leading to changes in gene transcription [120–122].”
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Burbach, K. M., Poland, A., & Bradfield, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8185 · Cited by 831 · cited 1×
“transcription factors [116].”
Reyes, H., Reisz-Porszasz, S., & Hankinson, O. (1992) · Science · doi:10.1126/science.256.5060.1193 · Cited by 777 · cited 1×
“leading to changes in gene transcription [120–122].”
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 749 · cited 1×
“significantly reduce the risk of AD [70–75].”
Monteleone, I., Rizzo, A., Sarra, M., Sica, G., Sileri, P., Biancone, L., MacDonald, T. T., Pallone, F., & Monteleone, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.007 · Cited by 656 · cited 1×
“AhR activation seems to be also important for cancer and inflammation, supporting the possibility of targeting the AhR for therapy in inflammation and a number of cancers [128–130].”
BackgroundAssociation of the Ah receptor with the 90-kDa heat shock protein.
Perdew, G. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68314-0 · Cited by 509 · cited 1×
“Non-ligand bound AhR is retained in the cytoplasm as an inactive protein complex bound to several co-chaperones [117–119].”
BackgroundKaruppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2008.10.008 · Cited by 485 · cited 1×
“significantly reduce the risk of AD [70–75].”
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
Giordano, S., & Petrelli, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503212 · Cited by 457 · cited 1×
“Now, there is a general agreement that molecules interfering simultaneously with multiple targets might be more effective than single target agents [2].”
BackgroundMeyer, B. K., Pray-Grant, M. G., Vanden Heuvel, J. P., & Perdew, G. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.978 · Cited by 386 · cited 1×
“Non-ligand bound AhR is retained in the cytoplasm as an inactive protein complex bound to several co-chaperones [117–119].”
BackgroundAryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries
Tijet, N., Boutros, P. C., Moffat, I. D., Okey, A. B., Tuomisto, J., & Pohjanvirta, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.018705 · Cited by 341 · cited 1×
“AhR plays a functional role in physiology and toxicology, especially in cellular proliferation and differentiation, the adaptive response, the toxic response, secretion of hormones and immunomodulation [123–127].”
BackgroundKazlauskas, A., Poellinger, L., & Pongratz, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13519 · Cited by 302 · cited 1×
“Non-ligand bound AhR is retained in the cytoplasm as an inactive protein complex bound to several co-chaperones [117–119].”
BackgroundProstaglandin E2 Receptor EP4 Contributes to Inflammatory Pain Hypersensitivity
Lin, C.-R., Amaya, F., Barrett, L., Wang, H., Takada, J., Samad, T. A., & Woolf, C. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105569 · Cited by 257 · cited 1×
“prostaglandin E2 (PGE2), which is the principal pro-inflammatory prostanoid and contributes to one of the key features of inflammation [19].”
BackgroundLuo, Z., Ma, L., Zhao, Z., He, H., Yang, D., Feng, X., Ma, S., Chen, X., Zhu, T., Cao, T., et al. (2012) · Cell Research · doi:10.1038/cr.2011.205 · Cited by 191
Treatment of Diabetes Using Traditional Chinese Medicine: Past, Present and Future
Tong, X.-L., Dong, L., Chen, L., & Zhen, Z. (2012) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x12500656 · Cited by 177 · cited 1×
“Chinese herbal medicines are attracting intensive attention because of their history of reliable therapeutic efficacy for the prevention and treatment of various human diseases for thousands of years [3–6].”
BackgroundKobayashi*, Y., Nakano, Y., Kizaki, M., Hoshikuma, K., Yokoo, Y., & Kamiya, T. (2001) · Planta Medica · doi:10.1055/s-2001-17353 · Cited by 176 · cited 1×
“evodiamine appeared to prevent obesity and reduce body fat [12].”
BackgroundTakada, Y., Kobayashi, Y., & Aggarwal, B. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500077200 · Cited by 172 · cited 1×
“found that evodiamine exhibited apoptotic activity by modulating NF-κB activation, which leads to inhibition of NF-κB-regulated gene products such as Cyclin D1, X chromosome-linked IAP (XIAP), Bcl-2, and Bcl-Xl [33].”
BackgroundFighting fire with fire: Poisonous Chinese herbal medicine for cancer therapy
Wang, S., Wu, X., Tan, M., Gong, J., Tan, W., Bian, B., Chen, M., & Wang, Y. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.041 · Cited by 165 · cited 1×
“Chinese herbal medicines are attracting intensive attention because of their history of reliable therapeutic efficacy for the prevention and treatment of various human diseases for thousands of years [3–6].”
BackgroundDong, G., Sheng, C., Wang, S., Miao, Z., Yao, J., & Zhang, W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100387d · Cited by 159 · cited 1×
“They also designed and synthesized a series of evodiamine analogues and investigated their structure-activity relationship [48].”
BackgroundA new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa
Moon, T. C., Murakami, M., Kudo, I., Son, K. H., Kim, H. P., Kang, S. S., & Chang, H. W. (1999) · Inflammation Research · doi:10.1007/s000110050512 · Cited by 159 · cited 1×
“Phytochemical studies have shown the presence of evodiamine (Figure 1), which is an indole alkaloid found in large amounts in the Chinese medicine evodia [10].”
BackgroundWang, Y., Fan, X., Qu, H., Gao, X., & Cheng, Y. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612801319034 · Cited by 158 · cited 1×
“In the past, the main effort was aimed at developing highly specific molecules acting on single targets [1].”
BackgroundThe vanilloid receptor TRPV1: Role in cardiovascular and gastrointestinal protection
Peng, J., & Li, Y. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.053 · Cited by 154
Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
Guerrant, W., Patil, V., Canzoneri, J. C., & Oyelere, A. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm200799p · Cited by 143 · cited 1×
“of representative cancer cell lines [97].”
Park, C., Kim, S.-H., Choi, W., Lee, Y.-J., Kim, J., Kang, S., & Sun, Y. (1996) · Planta Medica · doi:10.1055/s-2006-957926 · Cited by 143 · cited 1×
“chemical structure of dehydroevodiamine has been used as a basis in the clinical development of novel cholinesterase inhibitors [77].”
Ko, H.-C., Wang, Y.-H., Liou, K., Chen, C. A., Chen, C.-H., Wang, W.-Y., Chang, S., Hou, Y.-C., Chen, K.-T., Chen, C.-F., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.002 · Cited by 143 · cited 1×
“NO production in activated inflammatory cells [17].”
Liao, C.-H., Pan, S., Guh, J., Chang, Y.-L., Pai, H., Lin, C., & Teng, C. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi041 · Cited by 139 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundWang, T., Wang, Y., Kontani, Y., Kobayashi, Y., Sato, Y., Mori, N., & Yamashita, H. (2008) · Endocrinology · doi:10.1210/en.2007-0467 · Cited by 129 · cited 1×
“They also found that evodiamine improved leptin resistance and insulin sensitivity in the mice [52].”
BackgroundEvodiamine, a constituent of Evodiae Fructus, induces anti‐proliferating effects in tumor cells
Fei, X. F., Wang, B. X., Li, T. J., Tashiro, S., Minami, M., Xing, D. J., & Ikejima, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01358.x · Cited by 125 · cited 1×
“Growing evidence demonstrates that evodiamine represents an important compound possessing a wide spectrum of biological activities [11–14], suggesting that it might interact with a number of diverse targets to carry out its therapeutic effects.”
BackgroundYang, J. Y., Li-jun, W., Tashino, S.-I., Onodera, S., & Ikejima, T. (2008) · Free Radical Research · doi:10.1080/10715760802112791 · Cited by 123 · cited 1×
“Reactive oxygen species (ROS) and NO generations were also found to exhibit regulatory effects on functions of p53, p21, protein tyrosine kinase (PTK) and other signaling proteins involved in evodiamine-induced apoptosis [36–39].”
BackgroundChiou, W., Liao, J., & Chen, C. (1996) · Journal of Natural Products · doi:10.1021/np960161+ · Cited by 120
Protective effect of resveratrol against naphthalene-induced oxidative stress in mice
Şehırlı, Ö., Tozan, A., Omurtag, G. Z., Çetınel, Ş., Contuk, G., Gedik, N., & Şener, G. (2008) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2007.08.023 · Cited by 115 · cited 1×
“significantly reduce the risk of AD [70–75].”
Induction of mRNA specific for cytochrome P1-450 in wild type and variant mouse hepatoma cells.
Israel, D. I., & Whitlock, J. P. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44469-3 · Cited by 112 · cited 1×
“AhR plays a functional role in physiology and toxicology, especially in cellular proliferation and differentiation, the adaptive response, the toxic response, secretion of hormones and immunomodulation [123–127].”
BackgroundLee, T.-J., Kim, E. J., Kim, S., Jung, E. M., Park, J., Jeong, S. H., Park, S.-E., Yoo, Y. H., & Kwon, T. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0167 · Cited by 111 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundThe vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action
Chiou, W., Chou, C., Shum, A. Y., & Chen, C. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90039-7 · Cited by 103 · cited 1×
“Evodiamine showed a beneficial effect on cardiovascular diseases as reported previously [55–57].”
BackgroundTransient receptor potential vanilloid type 1 and pain development
Palazzo, E., Luongo, L., de Novellis, V., Rossi, F., Marabese, I., & Maione, S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.022 · Cited by 102 · cited 1×
“linked to processes mediating inflammation, cancer, cardiovascular diseases, obesity, skin diseases, and neuropathic pain [98–106].”
BackgroundLiao, J.-F., Chiou, W.-F., Shen, Y.-C., Wang, G.-J., & Chen, C.-F. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-6 · Cited by 100 · cited 1×
“abdominal pain, difficult menstruation, vomiting, diarrhea, and other diseases [9].”
BackgroundDNA Adduct Formation in Precision-Cut Rat Liver and Lung Slices Exposed to Benzo[a]pyrene
Harrigan, J. A., Vezina, C. M., McGarrigle, B. P., Ersing, N., Box, H. C., Maccubbin, A. E., & Olson, J. R. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfh030 · Cited by 100 · cited 1×
“AhR plays a functional role in physiology and toxicology, especially in cellular proliferation and differentiation, the adaptive response, the toxic response, secretion of hormones and immunomodulation [123–127].”
BackgroundAnti‐proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3
Kan, S., Yu, C., Pu, H., Hsu, J., Chen, M., & Wang, P. S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21036 · Cited by 99 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundBacterial DNA replication enzymes as targets for antibacterial drug discovery
Sanyal, G., & Doig, P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.660478 · Cited by 92 · cited 1×
“Topoisomerases have been also shown to have a potential for delivering antibacterial compounds or drug candidates [112,113].”
BackgroundMartin, E., Thougaard, A., Grauslund, M., Jensen, P. B., Björkling, F., Hasinoff, B. B., Tjørnelund, J., Sehested, M., & Jensen, L. H. (2008) · Toxicology · doi:10.1016/j.tox.2008.10.011 · Cited by 91 · cited 1×
“In addition, topoisomerases are involved in the cardiovascular and nervous system diseases [114,115].”
BackgroundChiou, W.-F., Sung, Y., Liao, J., Shum, A. Y., & Chen, C. (1997) · Journal of Natural Products · doi:10.1021/np960495z · Cited by 91 · cited 1×
“7 [16].”
Choi, Y. H., Shin, E. M., Kim, Y. S., Cai, X. F., Lee, J. J., & Kim, H. P. (2006) · Archives of Pharmacal Research · doi:10.1007/bf02968573 · Cited by 90 · cited 1×
“Growing evidence demonstrates that evodiamine represents an important compound possessing a wide spectrum of biological activities [11–14], suggesting that it might interact with a number of diverse targets to carry out its therapeutic effects.”
BackgroundAnti-Invasive and Metastatic Activities of Evodiamine.
Ogasawara, M., Matsunaga, T., Takahashi, S., Saiki, I., & Suzuki, H. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.1491 · Cited by 90 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundHamasaki, N., Ishii, E., Tominaga, K., Tezuka, Y., Nagaoka, T., Kadota, S., Kuroki, T., & Yano, I. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb01240.x · Cited by 89 · cited 1×
“Some compounds isolated from Evodia rutaecarpa were found to act as new anti-infectious agents, such as 3-dimethylallyl-4-methoxy-2-quinolone, 1-methyl-2-pentadecyl-4(1H)-quinolone, evocarpine, dihydroevocarpine and 1-methyl-2-[(Z)-8-tridecenyl]-4-(1H)-quinolone [78–82].”
BackgroundYuan, S.-M., Gao, K., Wang, D., Quan, X., Liu, J., Ma, C., Qin, C., & Zhang, L. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.230 · Cited by 87 · cited 2×
“Recently, the effect and the possible mechanisms of action of evodiamine in AD mouse models were investigated [76].”
BackgroundEffects of Green Tea Polyphenol on Cognitive and Acetylcholinesterase Activities
KIM, H. K., KIM, M., KIM, S., KIM, M., & CHUNG, J. H. (2004) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.68.1977 · Cited by 86 · cited 1×
“significantly reduce the risk of AD [70–75].”
The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
O’Donnell, E. F., Kopparapu, P., Koch, D. C., Jang, H. S., Phillips, J. L., Tanguay, R. L., Kerkvliet, N. I., & Kolluri, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040926 · Cited by 86
Wei, J., Ching, L. ‐., Zhao, J. ‐., Shyue, S., Lee, H. ‐., Kou, Y. R., & Lee, T. (2012) · Acta Physiologica · doi:10.1111/apha.12005 · Cited by 86 · cited 1×
“linked to processes mediating inflammation, cancer, cardiovascular diseases, obesity, skin diseases, and neuropathic pain [98–106].”
BackgroundOGASAWARA, M., Matsubara, T., & Suzuki, H. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.917 · Cited by 86 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundTRPV1 Channels Regulate Cortical Excitability in Humans
Mori, F., Ribolsi, M., Kusayanagi, H., Monteleone, F., Mantovani, V., Buttari, F., Marasco, E., Bernardi, G., Maccarrone, M., & Centonze, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2531-11.2012 · Cited by 85
Wang, C., Li, S., & Wang, M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.11.019 · Cited by 83 · cited 1×
“signaling pathways were also found to exhibit essential roles in the responses of tumor cells apoptosis induced by evodiamine [40–43].”
BackgroundWei, W., Chen, H., Wang, Z., Ni, Z., Liu, H., Tong, H., Guo, H., LIU, D.-L., & Lin, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.8.1 · Cited by 80 · cited 1×
“signaling pathways were also found to exhibit essential roles in the responses of tumor cells apoptosis induced by evodiamine [40–43].”
BackgroundSelf-citationThe Nociceptive and Anti-Nociceptive Effects of Evodiamine from Fruits ofEvodia rutaecarpain Mice
Kobayashi, Y. (2003) · Planta Medica · doi:10.1055/s-2003-39701 · Cited by 80 · cited 1×
“Growing evidence demonstrates that evodiamine represents an important compound possessing a wide spectrum of biological activities [11–14], suggesting that it might interact with a number of diverse targets to carry out its therapeutic effects.”
BackgroundHistamine H4 receptor insights into a potential therapeutic target in breast cancer
Medina, V. A. (2015) · Frontiers in Bioscience-Scholar · doi:10.2741/s420 · Cited by 77
Mechanisms of Disease: the role of gastrointestinal hormones in appetite and obesity
Vincent, R. P., Ashrafian, H., & le Roux, C. W. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1118 · Cited by 75 · cited 1×
“Moreover, evodiamine inhibited both gastric emptying and gastrointestinal transit, whereas increased the plasma concentration of cholecystokinin (CCK) in a dose-dependent manner, which plays a key role in regulation of digestion and appetite [53,54].”
BackgroundInhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP
Kan, S., Huang, W. J., Lin, L., & Wang, P. S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20138 · Cited by 75 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundRole of the transient receptor potential vanilloid 1 in inflammation and sepsis
Montiel, A. V. F., Devesa, Planells-Cases, Fernandez-Ballester, G. J., González-Ros, J. M., & Montiel, A. V. F. (2011) · Journal of Inflammation Research · doi:10.2147/jir.s12978 · Cited by 74
Hu, C., Xiao, L., Deng, H., & Li, Y. (2002) · Planta Medica · doi:10.1055/s-2002-33794 · Cited by 73
Pollenz, R. S., & Barbour, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6095-6104.2000 · Cited by 72 · cited 1×
“leading to changes in gene transcription [120–122].”
Zhao, J., Yang, P., Fan, L., Tao, L., Ding, H., Rui, Y., Cao, Z., & Zhang, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044938 · Cited by 72 · cited 1×
“and immune regulation [8].”
Kobayashi, Y., Hoshikuma, K., Nakano, Y., Yokoo, Y., & Kamiya, T. (2001) · Planta Medica · doi:10.1055/s-2001-12008 · Cited by 72 · cited 1×
“In addition, several studies showed that evodiamine produced transient positive inotropic and chronotropic effects on the guinea-pig isolated atria [61].”
BackgroundEvodiamine inhibits adipogenesis via the EGFR–PKCα–ERK signaling pathway
Wang, T., Wang, Y., & Yamashita, H. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.046 · Cited by 69 · cited 1×
“simulating the ERK/MAPK signaling pathway, which modulated the expression of the adipocyte specific transcription factors and Akt signaling [51].”
BackgroundEvodiamine functions as an agonist for the vanilloid receptor TRPV1
Pearce, L. V., Petukhov, P. A., Szabó, T. G., Kedei, N., Bizik, F., Kozikowski, A. P., & Blumberg, P. M. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b404506h · Cited by 67 · cited 1×
“87 microM, and yielded an EC50 value of 856 ± 43 nM [85].”
BackgroundEvodiamine induces tumor cell death through different pathways: apoptosis and necrosis.
Zhang, Y., Li-jun, W., Tashiro, S., Onodera, S., & Ikejima, T. (2004) · PubMed · Cited by 66
Liu, Y.-N., Pan, S., Liao, C.-H., Huang, D.-Y., Guh, J., Peng, C.-Y., Chang, Y.-L., & Teng, C. (2009) · Shock · doi:10.1097/shk.0b013e31819940cb · Cited by 66 · cited 1×
“(HIF-1α) accumulation via dephosphorylation of the serine/threonine protein kinase B (PKB/Akt) and the 70 kDa ribosomal S6 kinase (p70S6k), providing evidence for a novel mechanism underlying its anti-inflammatory activity [18].”
BackgroundChinese herbal medicines for hypercholesterolemia
Liu, Z. L., Liu, J., Zhang, A. L., Wu, Q., Ruan, Y., Lewith, G. T., & Visconte, D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008305.pub2 · Cited by 64 · cited 1×
“Chinese herbal medicines are attracting intensive attention because of their history of reliable therapeutic efficacy for the prevention and treatment of various human diseases for thousands of years [3–6].”
BackgroundYang, J. Y., Li-jun, W., Tashino, S.-I., Onodera, S., & Ikejima, T. (2007) · Free Radical Research · doi:10.1080/10715760701499356 · Cited by 63 · cited 1×
“Reactive oxygen species (ROS) and NO generations were also found to exhibit regulatory effects on functions of p53, p21, protein tyrosine kinase (PTK) and other signaling proteins involved in evodiamine-induced apoptosis [36–39].”
BackgroundPerrett, S., & Whitfield, P. J. (1995) · Planta Medica · doi:10.1055/s-2006-958073 · Cited by 62
Anti‐Proliferative Effects of Evodiamine on Human Thyroid Cancer Cell Line ARO
Chen, M., Yu, C., Wang, S., Pu, H., Kan, S., Lin, L., Chi, C., Ho, L. L., Lee, C., & Wang, P. S. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22716 · Cited by 61 · cited 1×
“Other studies further revealed that evodiamine increased the expression of the apoptosis inducer Bax and decreased that of the apoptosis suppressor Bcl-2, and then induced apoptosis through the caspase pathway [34,35].”
BackgroundEvodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells
Zhang, C., Fan, X., Xu, X. M., Yang, X., Wang, X., & Liang, H. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833d26a9 · Cited by 58 · cited 1×
“Other studies further revealed that evodiamine increased the expression of the apoptosis inducer Bax and decreased that of the apoptosis suppressor Bcl-2, and then induced apoptosis through the caspase pathway [34,35].”
BackgroundSelf-citationEvodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation
Heo, S., Yun, H., Yi, H., Noh, E., & Park, S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22109 · Cited by 57 · cited 1×
“production and NADPH oxidase activation, implicating that evodiamine has the potential for use as anti-atherosclerosis agents [67].”
BackgroundIn vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori
Tominaga, K., Higuchi, K., Hamasaki, N., Hamaguchi, M., Takashima, T., Tanigawa, T., Watanabe, T., Fujiwara, Y., Tezuka, Y., Nagaoka, T., et al. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf159 · Cited by 56 · cited 1×
“Some compounds isolated from Evodia rutaecarpa were found to act as new anti-infectious agents, such as 3-dimethylallyl-4-methoxy-2-quinolone, 1-methyl-2-pentadecyl-4(1H)-quinolone, evocarpine, dihydroevocarpine and 1-methyl-2-[(Z)-8-tridecenyl]-4-(1H)-quinolone [78–82].”
BackgroundYang, J. Y., Li-jun, W., Tashiro, S., Onodera, S., & Ikejima, T. (2008) · Free Radical Research · doi:10.1080/10715760701762407 · Cited by 54 · cited 1×
“Reactive oxygen species (ROS) and NO generations were also found to exhibit regulatory effects on functions of p53, p21, protein tyrosine kinase (PTK) and other signaling proteins involved in evodiamine-induced apoptosis [36–39].”
BackgroundMATSUDA, H., Jianxin, W. U., Tanaka, T., Iinuma, M., & Kubo, M. (1997) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.20.243 · Cited by 54
Wanner, S. P., Garami, A., Pákai, E., de Oliveira, D. L., Gavva, N. R., Coimbra, C. C., & Romanovsky, A. A. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18772 · Cited by 50 · cited 1×
“linked to processes mediating inflammation, cancer, cardiovascular diseases, obesity, skin diseases, and neuropathic pain [98–106].”
BackgroundIntracellular Regulation of Evodiamine-Induced A375-S2 Cell Death
Zhang, Y., Li-jun, W., Tashiro, S., Onodera, S., & Ikejima, T. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1543 · Cited by 50 · cited 1×
“In addition, evodiamine induced apoptosis of a variety of tumor cell lines through several pathways [30–32].”
BackgroundAtypical apoptosis in L929 cells induced by evodiamine isolated fromEvodia rutaecarpa
Zhang, Y., Zhang, Q., Li-jun, W., Tashiro, S., Onodera, S., & Ikejima, T. (2004) · Journal of Asian Natural Products Research · doi:10.1080/1028602031000119772 · Cited by 50
New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors
Sheng, C., Miao, Z., & Zhang, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200453 · Cited by 49 · cited 1×
“Moreover, evodiamine has recently been identified as a dual catalytic inhibitor of topoisomerases I and II [45–48].”
BackgroundIn Vitro and in Vivo Antiallergic Effect of the Fructus of Evodia rutaecarpa and Its Constituents
Shin, Y.-W., Bae, E., Cai, X. F., Lee, J. J., & Kim, D. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.197 · Cited by 48
Manipulating molecular switches in brown adipocytes and their precursors: A therapeutic potential
Birerdinc, A., Jarrar, M. H., Stotish, T., Randhawa, M., & Baranova, A. V. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.08.001 · Cited by 47 · cited 1×
“linked to processes mediating inflammation, cancer, cardiovascular diseases, obesity, skin diseases, and neuropathic pain [98–106].”
BackgroundHu, Y., Fahmy, H. T. Y., Zjawiony, J. K., & Davies, G. E. (2009) · Fitoterapia · doi:10.1016/j.fitote.2009.09.012 · Cited by 45 · cited 1×
“Evodiamine has excellent potential as an agent to prevent obesity [49].”
BackgroundProtective Effects of Evodiamine on Myocardial Ischemia-Reperfusion Injury in Rats
Rang, W., Du, Y., Hu, C., Ye, F., Xu, K.-P., Peng, J., Deng, H., & Li, Y. (2004) · Planta Medica · doi:10.1055/s-2004-835841 · Cited by 41 · cited 1×
“injury in rats by activation of vanilloid receptors to stimulate the CGRP release [65,66].”
BackgroundMezrich, J. D., Nguyen, L. P., Kennedy, G., Nukaya, M., Fechner, J. H., Zhang, X., Xing, Y., & Bradfield, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044547 · Cited by 40 · cited 1×
“AhR plays a functional role in physiology and toxicology, especially in cellular proliferation and differentiation, the adaptive response, the toxic response, secretion of hormones and immunomodulation [123–127].”
BackgroundThermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats
Tsai, T. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00317-c · Cited by 40 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundEffects of evodiamine on gastrointestinal motility in male rats
Wu, C.-L., Hung, C., Chang, F., Lin, L., Pau, K. ‐. F., & Wang, P. S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02687-0 · Cited by 40 · cited 1×
“Moreover, evodiamine inhibited both gastric emptying and gastrointestinal transit, whereas increased the plasma concentration of cholecystokinin (CCK) in a dose-dependent manner, which plays a key role in regulation of digestion and appetite [53,54].”
BackgroundKobayashi, Y., Nakano, Y., Hoshikuma, K., Yokoo, Y., & Kamiya, T. (2000) · Planta Medica · doi:10.1055/s-2000-8615 · Cited by 39 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundYang, J. Y., Li-jun, W., Tashino, S.-I., Onodera, S., & Ikejima, T. (2010) · Free Radical Research · doi:10.3109/10715762.2010.481302 · Cited by 38 · cited 1×
“Reactive oxygen species (ROS) and NO generations were also found to exhibit regulatory effects on functions of p53, p21, protein tyrosine kinase (PTK) and other signaling proteins involved in evodiamine-induced apoptosis [36–39].”
BackgroundAnti-Helicobacter pylori Activity of Quinolone Alkaloids from Evodiae Fructus.
Rho, T. C., Bae, E., Kim, D.-H., Oh, W. K., Kim, B. Y., Ahn, J. S., & Lee, H. S. (1999) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.22.1141 · Cited by 37 · cited 1×
“Some compounds isolated from Evodia rutaecarpa were found to act as new anti-infectious agents, such as 3-dimethylallyl-4-methoxy-2-quinolone, 1-methyl-2-pentadecyl-4(1H)-quinolone, evocarpine, dihydroevocarpine and 1-methyl-2-[(Z)-8-tridecenyl]-4-(1H)-quinolone [78–82].”
BackgroundAntianoxic action of evodiamine, an alkaloid in Evodia rutaecarpa fruit
Yamahara, J., Yamada, T., Kitani, T., Naitoh, Y., & Fujimura, H. (1989) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(89)90090-1 · Cited by 36 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundKano, Y., Qine, Z. O. N. G., & KOMATSU, K.-I. (1991) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.39.690 · Cited by 33 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundShi, J., Yan, J., Lei, Q., Zhao, J., Chen, K., Yang, D., Zhao, X., & Zhang, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.091 · Cited by 32 · cited 1×
“of evodiamine suppressed the neuropeptide Y (NPY) mRNA and peptide levels in the arcuate nucleus (ARC) of the hypothalamus, which might be one of the mechanisms by which evodiamine exerted its fat loss effects [50].”
BackgroundHu, Y., Ehli, E. A., Hudziak, J. J., & Davies, G. E. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.24 · Cited by 32 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundThe aryl hydrocarbon receptor in tumor immunity
Platten, M., Litzenburger, U. M., & Wick, W. (2012) · OncoImmunology · doi:10.4161/onci.19071 · Cited by 30 · cited 1×
“AhR activation seems to be also important for cancer and inflammation, supporting the possibility of targeting the AhR for therapy in inflammation and a number of cancers [128–130].”
BackgroundHaji, A., Momose, Y., Takeda, R., Nakanishi, S., Horiuchi, T., & Arisawa, M. (1994) · Journal of Natural Products · doi:10.1021/np50105a009 · Cited by 26 · cited 1×
“significantly reduce the risk of AD [70–75].”
Protective Effects of Rutaecarpine in Cardiac Anaphylactic Injury is Mediated by CGRP
Yi, H.-H., Rang, W., Deng, P.-Y., Hu, C.-P., Liu, G.-Z., Tan, G., Xu, K.-P., & Li, Y.-J. (2004) · Planta Medica · doi:10.1055/s-2004-835840 · Cited by 24 · cited 1×
“Previous investigations also indicated that evodiamine possessed a protective effect of cardiac anaphylactic injury by stimulation of calcitonin gene-related peptide (CGRP) release [62–64].”
ResultBinding Mode Prediction of Evodiamine within Vanilloid Receptor TRPV1
Wang, Z., Sun, L., Yu, H., Zhang, Y., Gong, W., Jin, H., Zhang, L., & Liang, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078958 · Cited by 23 · cited 1×
“TRPV1 using homology modeling, molecular docking, dynamics simulation and pharmacophore modeling methods [107].”
MethodSelf-citationYu, P., Chao, H., Wang, S., & Wang, P. S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22276 · Cited by 22 · cited 1×
“many other biological functions, such as thermoregulatory effect, antianoxic action, dermatological applications, bronchoconstrictive action, and hormones secretion [88–96].”
BackgroundWang, C., Wang, M., Tashiro, S., et al. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.984 · Cited by 21 · cited 1×
“Evodiamine has been shown to exhibit anti-tumor properties by inhibiting proliferation of various cancer cell lines, including cervical cancer cells, colon cancer cells, lung cancer cells, melanoma cells, leukemic T-lymphocyte cells, prostate cancer cells and breast cancer cells [20–28].”
BackgroundRang, W., Du, Y., Hu, C., Ye, F., Tan, G., Deng, H., & Li, Y. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0677-0 · Cited by 19 · cited 1×
“Previous investigations also indicated that evodiamine possessed a protective effect of cardiac anaphylactic injury by stimulation of calcitonin gene-related peptide (CGRP) release [62–64].”
ResultLee, C., & Riddick, D. S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-099 · Cited by 18
Evodiamine as a novel antagonist of aryl hydrocarbon receptor
Yu, H., Tu, Y.-J., Zhang, C., Fan, X., Wang, X., Wang, Z., & Liang, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.122 · Cited by 17 · cited 11×
“Up to data, three proteins are believed to be direct targets of evodiamine, including TRPV1, the aryl hydrocarbon receptor (AhR), and topoisomerases I and II.”
BackgroundSelf-citationInhibitory effect of evodiamine on aldosterone release by Zona glomerulosa cells in male rats.
Hung, P. H., Lin, L., Wang, G.-J., Chen, C., & Wang, P. S. (2001) · PubMed · Cited by 16
Chao, D., Lin, L., Hsiang, C., Li, C., Lo, H., Liang, J., Kao, S.-T., Wu, S., & Ho, T. (2011) · Phytotherapy Research · doi:10.1002/ptr.3392 · Cited by 15 · cited 1×
“signaling pathways were also found to exhibit essential roles in the responses of tumor cells apoptosis induced by evodiamine [40–43].”
BackgroundYu, J., Tan, G., Deng, P.-Y., Xu, K.-P., Hu, C., & Li, Y. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.001 · Cited by 15 · cited 1×
“Previous investigations also indicated that evodiamine possessed a protective effect of cardiac anaphylactic injury by stimulation of calcitonin gene-related peptide (CGRP) release [62–64].”
ResultTopoisomerase IIβ regulates base excision repair capacity of neurons
Gupta, K. P., Swain, U., Rao, K. S., & Kondapi, A. K. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.03.010 · Cited by 15 · cited 1×
“In addition, topoisomerases are involved in the cardiovascular and nervous system diseases [114,115].”
BackgroundTominaga, K., Higuchi, K., Hamasaki, N., Tanigawa, T., Sasaki, E., Watanabe, T., Fujiwara, Y., Oshitani, N., Arakawa, T., Ishii, E., et al. (2005) · PubMed · Cited by 3
Metadata
- Authors
- Yu, H., Jin, H., Gong, W., Wang, Z., & Liang, H.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2013-01-31
- Volume
- 18
- Issue
- 2
- Pages
- 1826-1843
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2049217551
- Cited by
- 175
- References
- 109
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.